Funding the Cure with Dr. Travis Stiles

I had the pleasure of interviewing Dr. Travis Stiles CEO of Novoron Bioscience, Inc. Novoron is a private biotech company developing novel therapeutic approaches in...
video

Big Race Tonight at Talladega! SRA MS Awareness 1/15/18

Max Speed TV will bring us the exciting action tonight. It’s the 3rd race in the chase. Online racing starts at 7:30pm EST.  Click...

Roche’s star MS medicine Ocrevus wins EU approval

ZURICH (Reuters) - The European Union approved Roche’s multiple sclerosis medicine Ocrevus, one the Swiss company’s key new drugs that likely neared $1 billion...

Allcbdoilbenefits.com released the updated list of best pain relief oils for 2018

Blogger Aaron with allcbdoilbenefits.com compiled his annual list of the CBD oils that best help to control pain.What is CBD hemp oil and how...

Multiple Sclerosis (MS) Symptoms: Pruritus (Itching)

Overview: Pruritus (Itching)Similar to other neurological sensations and symptoms with multiple sclerosis such as burning, pain, pins and needles pruritus often comes on suddenly...
video

Multiple Sclerosis (MS) Symptoms: Torso Tightness (aka: “MS Hug”)

Overview:The “MS Hug” or “girdling” as it is often referred to is a feeling of tightness occurring in a person’s chest, waist and/or torso...

Advanced Practice Providers Treat Significantly More of their Multiple Sclerosis Patients with Monoclonal Antibody...

Market access restrictions for high efficacy Multiple Sclerosis therapies may be hindering their ability to optimally treat their clinically complex, relapsing patients, according to...

USA Survey Shows Most Women Newly Diagnosed with MS Have Concerns They Aren’t Discussing...

FRAZER, Pa. and AVON, Colo.–(BUSINESS WIRE)–Approximately 400,000 people in the U.S. have Multiple sclerosis (MS), an unpredictable disease of the central nervous system that...

Novartis multiple sclerosis drug Gilenya shows siginificant effect against pediatric MS in phase III...

Novartis MS Drug Gilenya shows siginificant effect in phase III trial: Against Pediatric MSNovartis’ multiple sclerosis (MS) drug Gilenya (fingolimod) has demonstrated significant effect...

Neuron Death and Muscle Wasting or Paralysis with MS

Neuron Death and Muscle Wasting or Paralysis with MSby Erika Lyons RichardsonAbout 20% of Multiple Sclerosis patients remain asymptomatic or become only mildly symptomatic...

Social Media

683FollowersFollow